Search results for "Vaccination."

showing 10 items of 654 documents

Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pne…

2022

As infection with Streptococcus pneumoniae is an important cause of pneumonia in children, the World Health Organization recommends childhood pneumococcal conjugate vaccines (PCVs). In January 2017, PCV universal mass vaccination (UMV) was introduced in Poland for children aged <2 years. The objective of this study was to estimate and describe the trends in the incidences of various types of pneumonia hospitalizations in Poland before (2013–2016) and after (2017–2018) introduction of the UMV program. The study was conducted at the regional hospitals of Opole and Bialystok and included all hospitalized children aged <2 years with a primary or secondary diagnosis of pneumonia in their electro…

PharmacologyImmunologyImmunology and AllergyPneumonia; pneumococcal conjugate vaccine; PHiD-CV; universal mass vaccination; Poland; incidence; chest radiograph; ICD-10Human Vaccines & Immunotherapeutics
researchProduct

Educational Interventions on Pregnancy Vaccinations during Childbirth Classes Improves Vaccine Coverages among Pregnant Women in Palermo’s Province

2021

Maternal immunization is considered the best intervention in order to prevent influenza infection of pregnant women and influenza and pertussis infection of newborns. Despite the existing recommendations, vaccination coverage rates in Italy remain very low. Starting from August 2018, maternal immunization against influenza and diphtheria-tetanus-pertussis were strongly recommended by the Italian Ministry of Health. We conducted a cross sectional study to estimate the effectiveness of an educational intervention, conducted during childbirth classes in three general hospitals in the Palermo metropolitan area, Italy, on vaccination adherence during pregnancy. To this end, a questionnaire on kn…

PharmacologyImmunologydiphtheria-tetanus-pertussis vaccinationChildbirth courses Diphtheria-tetanus-pertussis vaccination Influenza vaccination Maternal immunization Vaccination counselingRSettore MED/42 - Igiene Generale E ApplicataArticleinfluenza vaccinationInfectious Diseasesmaternal immunization; influenza vaccination; diphtheria-tetanus-pertussis vaccination; childbirth courses; vaccination counselingDrug DiscoveryMedicinePharmacology (medical)vaccination counselingmaternal immunizationchildbirth coursesVaccines
researchProduct

Influenza Vaccination and COVID-19 Outcomes in People Older than 50 Years: Data from the Observational Longitudinal SHARE Study

2022

Existing literature on the association between influenza vaccination and COVID-19 infection/outcomes is conflicting. Therefore, we aimed to investigate the association between influenza vaccination and COVID-19 outcomes in a large cohort of adults who participated in the SHARE (Survey of Health, Ageing, and Retirement in Europe). Information regarding influenza vaccination in the previous year, and medical and demographic characteristics, were self-reported. Positivity for COVID-19, symptomatology, and hospitalization were also ascertained using self-reported information. An adjusted logistic regression analysis (including 15 baseline factors or propensity score) was used to assess the asso…

PharmacologyInfectious DiseasesDrug DiscoveryImmunologySHARE studyCOVID-19Pharmacology (medical)influenza; vaccination; COVID-19; SHARE studyCOVID-19 SHARE study influenza vaccinationCOVID-19; SHARE study; influenza; vaccinationinfluenzavaccination
researchProduct

Safety of Rotavirus Vaccination in Preterm Infants Admitted in Neonatal Intensive Care Units in Sicily, Italy: A Multicenter Observational Study

2023

Rotavirus (RV) is among the most common vaccine-preventable diseases in children under five years of age. Despite the severity of rotavirus pathology in early childhood, rotavirus vaccination for children admitted to the neonatal intensive care unit (NICU), who are often born preterm and with various previous illnesses, is not performed. This multicenter, 3-year project aims to evaluate the safety of RV vaccine administration within the six main neonatal intensive care units of the Sicilian Region to preterm infants. Methods: Monovalent live attenuated anti-RV vaccination (RV1) was administered from April 2018 to December 2019 to preterm infants with gestational age &ge; 28 weeks. Vaccine a…

PharmacologyInfectious DiseasesrotaviruDrug DiscoveryImmunologyrotavirus vaccinationPharmacology (medical)rotavirus; rotavirus gastroenteritis; hospitalizations; rotavirus vaccination; preterm infantspreterm infantsrotavirus gastroenteritihospitalizationVaccines; Volume 11; Issue 4; Pages: 718
researchProduct

Network Analysis of Well-Being Dimensions in Vaccinated and Unvaccinated Samples of University Students from Poland during the Fourth Wave of the COV…

2022

Although numerous studies investigated the predictors of vaccination intention and decision, little is known about the relationship between vaccination and well-being. This study compares the physical and mental health dimensions among vaccinated and unvaccinated people. In a cross-sectional online survey, 706 university students from Poland (mean age of 23 years, 76% of women) participated in this study during the fourth pandemic wave (November–December 2021). Standardized questionnaires with a Likert response scale were included in the survey to measure spirituality, exposure to the COVID-19 pandemic, perceived physical health, stress, coronavirus-related PTSD, fear of COVID-19, anxiety, …

PharmacologyInfectious Diseasessubjective well-beingDrug DiscoveryImmunologyvaccination intention and decisionPharmacology (medical)mental health; network analysis; physical health; subjective well-being; university students; vaccination intention and decisionuniversity studentsnetwork analysisphysical healthmental healthVaccines
researchProduct

549 An RNA-lipoplex (RNA-LPX) vaccine demonstrates strong immunogenicity and promising clinical activity in a Phase I trial in cutaneous melanoma pat…

2021

BackgroundLipo-MERIT is an ongoing, first-in-human, open-label, dose-escalation Phase I trial investigating safety, tolerability and immunogenicity of BNT111 in patients with advanced melanoma. BNT111 is an RNA-LPX vaccine targeting the melanoma tumor-associated antigens (TAAs) New York esophageal squamous cell carcinoma 1 (NY-ESO-1), tyrosinase, melanoma-associated antigen 3 (MAGE-A3), and transmembrane phosphatase with tensin homology (TPTE). A previous exploratory interim analysis showed that BNT111, alone or combined with immune checkpoint inhibition (CPI), has a favorable adverse event (AE) profile, gives rise to antigen-specific T-cell responses and induces durable objective responses…

PharmacologyOncologyCancer Researchmedicine.medical_specialtybusiness.industryImmunogenicityELISPOTMelanomaImmunologyInterim analysismedicine.diseaseVaccinationOncologyTolerabilityInternal medicineCutaneous melanomamedicineMolecular MedicineImmunology and AllergyAdverse effectbusinessJournal for ImmunoTherapy of Cancer
researchProduct

Rotavirus and the web: analysis of online conversations in Italy during 2020

2021

Rotavirus is the most common cause of severe diarrhea among children worldwide. In 2017, Italy included rotavirus vaccination in its National Immunization Program. The use of social media monitoring, an efficient tool to understand vaccine hesitancy, has increased in recent years; however, only a few examples of such monitoring are available for Italy. Present study analyzed content on online sources, including social media, to identify factors contributing to Italian parents' decisions to vaccinate or not their children against rotavirus. Blogmeter Suite was used to search and analyze conversations related to rotavirus in Italian on online sources during 2020. These data were compared with…

PharmacologyRotavirusmedicine.medical_specialtyVaccination scheduleCommunicationImmunologyVaccinationRotavirus VaccinesCOVID-19Diseasemedicine.disease_causeRotavirus vaccineVaccinationItalyparents rotavirus social media vaccination vaccine hesitancy web listeningFamily medicineRotavirusmedicineImmunology and AllergyHumansActive listeningSocial mediaMisinformationPsychologyChild
researchProduct

Multidimensional Frailty and Vaccinations in Older People: A Cross-Sectional Study

2022

It is known that influenza, herpes zoster, pneumococcal and pertussis infections may increase morbidity and mortality in older people. Vaccinations against these pathogens are effective in older adults. Frailty seems to be an important determinant of vaccination rates, yet data supporting this association are still missing. Therefore, we aimed to investigate the prevalence of four recommended vaccinations (influenza, herpes zoster, pneumococcal and diphtheria-tetanus-pertussis) and the association with multidimensional frailty assessed using a self-reported comprehensive geriatric assessment tool, i.e., the multidimensional prognostic index (SELFY-MPI). Older participants visiting the outpa…

PharmacologySettore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/09 - Medicina InternapneumococcuImmunologydiphtheria-tetanus-pertussisherpes zostermultidimensional prognostic index; vaccination; influenza; herpes zoster; pneumococcus; diphtheria-tetanus-pertussisvaccinationSettore MED/42 - Igiene Generale E Applicatamultidimensional prognostic indexdiphtheria-tetanus-pertussivaccination.Infectious DiseasesDrug DiscoveryPharmacology (medical)diphtheria-tetanus-pertussis; herpes zoster; influenza; multidimensional prognostic index; pneumococcus; vaccinationinfluenzapneumococcusVaccines; Volume 10; Issue 4; Pages: 555
researchProduct

Factors Associated with Anti-SARS-CoV-2 Vaccine Acceptance among Pregnant Women: Data from Outpatient Women Experiencing High-Risk Pregnancy

2023

Pregnant women are at higher risk of severe Coronavirus disease 2019 (COVID-19) complications than non-pregnant women. The initial exclusion of pregnant women from anti-SARS-CoV-2 vaccines clinical trials has caused a lack of conclusive data about safety and efficacy for this vulnerable population. This cross-sectional study aims to define the factors related to vaccination adherence in a sample of women experiencing high-risk pregnancies. The recruited women completed a questionnaire based on the Health Belief Model. Data were analyzed to evaluate the associations between socio-demographic variables and vaccination acceptance through descriptive, univariate and multivariate logistic analys…

PharmacologycommunicationImmunologyvaccine acceptanceInfectious Diseaseseducational levelDrug Discoverygynecologistanti-SARS-CoV-2 vaccinationbarriervaccine hesitancyPharmacology (medical)high-risk pregnant womenCOVIDHealth Belief ModelCOVID Health Belief Model anti-SARS-CoV-2 vaccination barrier communication educational level gynecologist high-risk pregnant women vaccine acceptance vaccine hesitancy
researchProduct

Knowledge, Attitudes, Perceptions and Vaccination Acceptance/Hesitancy among the Community Pharmacists of Palermo’s Province, Italy: From Influenza t…

2022

In Italy, following the start of the SARS-CoV-2 vaccination campaign, community pharmacies (CPs) were recruited on a voluntary basis in order to administer COVID-19 vaccines as part of their activities. The aim of the present study was to investigate the knowledge, attitudes, and practices regarding SARS-CoV-2 infection prevention, and vaccine acceptance/hesitancy towards COVID-19 and influenza vaccinations among the community pharmacists operating in the Palermo Province. A cross-sectional study was conducted, with two different questionnaires administered before and after the conduction of the vaccination campaign against SARS-CoV-2 at the COVID-19 vaccination center of the Palermo Univer…

Pharmacologycommunity pharmacistInfectious DiseasesCOVID-19 vaccinationSARS-CoV-2 infectionhealthcare professionalDrug DiscoveryImmunologyPharmacology (medical)influenza vaccinationvaccine hesitancy.influenza vaccination; COVID-19 vaccination; community pharmacists; KAPs; vaccine hesitancy; healthcare professionals; SARS-CoV-2 infectionVaccines
researchProduct